Focus
immunotherapy
FDA Approves 1st T-Cell Therapy for Melanoma
The therapy was granted accelerated approval for its use in treating patients with metastatic and unremovable melanoma.
Cancer Patients With Mutated Mitochondria Respond Better to Treatment
Mutated mitochondrial DNA is common among cancer patients, and luckily, it may provide a way to bolster treatment.
